Tigabu Kassa

Array ( [id] => 7428297 [patent_doc_number] => 20040161794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Biosynthesis of HIF' [patent_app_type] => new [patent_app_number] => 10/601184 [patent_app_country] => US [patent_app_date] => 2003-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11518 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20040161794.pdf [firstpage_image] =>[orig_patent_app_number] => 10601184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7395644 [patent_doc_number] => 20040022773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Cancer cell receptor-expressing natural killer cell lines and methods of use' [patent_app_type] => new [patent_app_number] => 10/456620 [patent_app_country] => US [patent_app_date] => 2003-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 19966 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20040022773.pdf [firstpage_image] =>[orig_patent_app_number] => 10456620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7395242 [patent_doc_number] => 20040018183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Modified natural killer cell lines and methods of use' [patent_app_type] => new [patent_app_number] => 10/456829 [patent_app_country] => US [patent_app_date] => 2003-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19960 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20040018183.pdf [firstpage_image] =>[orig_patent_app_number] => 10456829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7395237 [patent_doc_number] => 20040018182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Thymidine kinase expressing natural killer cell lines and methods of use' [patent_app_type] => new [patent_app_number] => 10/456779 [patent_app_country] => US [patent_app_date] => 2003-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 19929 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20040018182.pdf [firstpage_image] =>[orig_patent_app_number] => 10456779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7459979 [patent_doc_number] => 20040052770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Interleukin-secreting natural killer cell lines and methods of use' [patent_app_type] => new [patent_app_number] => 10/456237 [patent_app_country] => US [patent_app_date] => 2003-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19949 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20040052770.pdf [firstpage_image] =>[orig_patent_app_number] => 10456237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7355650 [patent_doc_number] => 20040013607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells' [patent_app_type] => new [patent_app_number] => 10/446689 [patent_app_country] => US [patent_app_date] => 2003-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10784 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20040013607.pdf [firstpage_image] =>[orig_patent_app_number] => 10446689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6701573 [patent_doc_number] => 20030224453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Structural models for cytoplasmic domains of transmembrane receptors' [patent_app_type] => new [patent_app_number] => 10/447292 [patent_app_country] => US [patent_app_date] => 2003-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6079 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20030224453.pdf [firstpage_image] =>[orig_patent_app_number] => 10447292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7607749 [patent_doc_number] => 07097965 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-29 [patent_title] => 'Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein' [patent_app_type] => utility [patent_app_number] => 10/446890 [patent_app_country] => US [patent_app_date] => 2003-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10059 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/097/07097965.pdf [firstpage_image] =>[orig_patent_app_number] => 10446890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7355987 [patent_doc_number] => 20040013665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Immunoreactive peptides from Epstein-Barr virus' [patent_app_type] => new [patent_app_number] => 10/442456 [patent_app_country] => US [patent_app_date] => 2003-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12457 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20040013665.pdf [firstpage_image] =>[orig_patent_app_number] => 10442456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7133493 [patent_doc_number] => 20040043019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Method of treating immune-mediated diseases by administration of IgM' [patent_app_type] => new [patent_app_number] => 10/438118 [patent_app_country] => US [patent_app_date] => 2003-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2690 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043019.pdf [firstpage_image] =>[orig_patent_app_number] => 10438118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6731034 [patent_doc_number] => 20030187224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Chimeric OPG polypeptides' [patent_app_type] => new [patent_app_number] => 10/436826 [patent_app_country] => US [patent_app_date] => 2003-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9379 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20030187224.pdf [firstpage_image] =>[orig_patent_app_number] => 10436826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6678164 [patent_doc_number] => 20030228304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Chimeric antibodies for delivery of antigens to selected cells of the immune system' [patent_app_type] => new [patent_app_number] => 10/428754 [patent_app_country] => US [patent_app_date] => 2003-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10086 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20030228304.pdf [firstpage_image] =>[orig_patent_app_number] => 10428754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7395589 [patent_doc_number] => 20040018204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Compositions and methods for WT1 specific immunotherapy' [patent_app_type] => new [patent_app_number] => 10/427717 [patent_app_country] => US [patent_app_date] => 2003-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 62474 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20040018204.pdf [firstpage_image] =>[orig_patent_app_number] => 10427717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7243464 [patent_doc_number] => 20050271653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Methods and devices for targeting a site in a mammal and for removing species from a mammal' [patent_app_type] => utility [patent_app_number] => 10/511818 [patent_app_country] => US [patent_app_date] => 2003-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 20063 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0271/20050271653.pdf [firstpage_image] =>[orig_patent_app_number] => 10511818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7225761 [patent_doc_number] => 20050255152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'System for enhanced targeted delivery' [patent_app_type] => utility [patent_app_number] => 10/511413 [patent_app_country] => US [patent_app_date] => 2003-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11703 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20050255152.pdf [firstpage_image] =>[orig_patent_app_number] => 10511413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7440023 [patent_doc_number] => 20040009168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Multidose antibody formulation' [patent_app_type] => new [patent_app_number] => 10/409477 [patent_app_country] => US [patent_app_date] => 2003-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7872 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009168.pdf [firstpage_image] =>[orig_patent_app_number] => 10409477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6821302 [patent_doc_number] => 20030219463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'T cell receptor transfer into a candidate effector cell or a precursor thereof' [patent_app_type] => new [patent_app_number] => 10/391521 [patent_app_country] => US [patent_app_date] => 2003-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7816 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20030219463.pdf [firstpage_image] =>[orig_patent_app_number] => 10391521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6710509 [patent_doc_number] => 20030170258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Novel processes implementing selective immune down regulation (SIDR)' [patent_app_type] => new [patent_app_number] => 10/385440 [patent_app_country] => US [patent_app_date] => 2003-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 23039 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170258.pdf [firstpage_image] =>[orig_patent_app_number] => 10385440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7403654 [patent_doc_number] => 20040023909 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Process for preventing or reducing undesirable immunological effects to infectious agents in subjects' [patent_app_type] => new [patent_app_number] => 10/377603 [patent_app_country] => US [patent_app_date] => 2003-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20429 [patent_no_of_claims] => 125 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023909.pdf [firstpage_image] =>[orig_patent_app_number] => 10377603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7395615 [patent_doc_number] => 20040022768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Process useful for producing selective immune down regulation (SIDR) in subjects, including adult subjects to artificially expressed gene, gene delivery systems, infectious agents, and non-cellular immunogenic components, and processes for producing immunological tolerance in subjets using SIDR' [patent_app_type] => new [patent_app_number] => 10/377628 [patent_app_country] => US [patent_app_date] => 2003-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20372 [patent_no_of_claims] => 125 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20040022768.pdf [firstpage_image] =>[orig_patent_app_number] => 10377628 [rel_patent_id] =>[rel_patent_doc_number] =>)